Chandra Bhagat Pharma Limited (BOM:542934)
63.00
+3.00 (5.00%)
At close: Nov 16, 2026
Chandra Bhagat Pharma Revenue
Chandra Bhagat Pharma had revenue of 912.35M INR in the half year ending March 31, 2026, a decrease of -11.63%. This brings the company's total for the last twelve months to 1.74B, up 252.01% year-over-year. In the fiscal year ending March 31, 2026, Chandra Bhagat Pharma had annual revenue of 1.17B with 28.53% growth. That makes Chandra Bhagat Pharma the 34,368th largest company in the world by revenue and 2,727th in India.
Revenue (ttm)
1.74B
Revenue Growth
+252.01%
P/S Ratio
0.26
Revenue / Employee
38.64M
Employees
45
Market Cap
475.34M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 1.17B | 259.24M | 28.53% |
| Mar 31, 2025 | 908.56M | -1.32B | -59.17% |
| Mar 31, 2024 | 2.23B | 1.03B | 85.93% |
| Mar 31, 2023 | 1.20B | 255.97M | 27.21% |
| Mar 31, 2022 | 940.76M | 233.79M | 33.07% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Centuple Global | 5.62B |
| Dipna Pharmachem | 1.31B |
| VijayPD Ceutical | 1.00B |
| Medico Intercontinental | 864.77M |
| Medistep Healthcare | 731.36M |
| Zenlabs Ethica | 485.60M |
| Constronics Infra | 454.43M |
| Goldline Pharmaceutical | 311.98M |